A Low Dose of Hydrous Icaritin Nano-Formulation with Remarkable Efficacy and Tumor Targeting in Cancer Therapy
Jingxin Fu(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiangtao Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yifei Guo(Chinese Academy of Medical Sciences & Peking Union Medical College), Haowen Li(Dalian Medical University), Meihua Han(Chinese Academy of Medical Sciences & Peking Union Medical College), Hui Ao(Anhui University of Traditional Chinese Medicine), Yian Wang(Hunan Normal University), Likang Lu(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 3
Related Papers
TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth
|Cell|2006|1.4k
Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|718
A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy response
|Nature Communications|2020|246
Epstein–Barr Virus–Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1
|Cancer Research|2021|220
Tumor Susceptibility of <i>Rassf1a</i> Knockout Mice
|Cancer Research|2005|214